- Home
- FGI vs XBIO Comparison
FGI vs XBIO Comparison
Compare FGI & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- XBIO
- Stock Information
- Founded
- FGI 1987
- XBIO N/A
- Country
- FGI United States
- XBIO United States
- Employees
- FGI N/A
- XBIO N/A
- Industry
- FGI Industrial Specialties
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- XBIO Health Care
- Exchange
- FGI Nasdaq
- XBIO Nasdaq
- Market Cap
- FGI 5.1M
- XBIO 4.2M
- IPO Year
- FGI 2022
- XBIO N/A
- Fundamental
- Price
- FGI $0.56
- XBIO $2.91
- Analyst Decision
- FGI
- XBIO Hold
- Analyst Count
- FGI 0
- XBIO 1
- Target Price
- FGI N/A
- XBIO N/A
- AVG Volume (30 Days)
- FGI 286.2K
- XBIO 9.5K
- Earning Date
- FGI 05-13-2025
- XBIO 05-13-2025
- Dividend Yield
- FGI N/A
- XBIO N/A
- EPS Growth
- FGI N/A
- XBIO N/A
- EPS
- FGI N/A
- XBIO N/A
- Revenue
- FGI $134,277,102.00
- XBIO $2,582,728.00
- Revenue This Year
- FGI $8.04
- XBIO $14.23
- Revenue Next Year
- FGI $6.41
- XBIO N/A
- P/E Ratio
- FGI N/A
- XBIO N/A
- Revenue Growth
- FGI 11.13
- XBIO 5.63
- 52 Week Low
- FGI $0.46
- XBIO $2.20
- 52 Week High
- FGI $1.36
- XBIO $5.20
- Technical
- Relative Strength Index (RSI)
- FGI 46.95
- XBIO 49.56
- Support Level
- FGI $0.50
- XBIO $2.78
- Resistance Level
- FGI $0.81
- XBIO $3.22
- Average True Range (ATR)
- FGI 0.07
- XBIO 0.24
- MACD
- FGI 0.01
- XBIO 0.03
- Stochastic Oscillator
- FGI 23.48
- XBIO 34.16
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.